Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Yarrow Bioscience Inc., 2 years.
Yarrow Bioscience Inc.
Director
Phathom Pharmaceuticals Inc.
Director · President and CEO
Chief executive roles
Phathom Pharmaceuticals Inc.
· President and CEO
Since April 2025
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Phathom Pharmaceuticals Inc. | Grant or award | +12,362 | — | — |
| Feb 10, 2026 | Phathom Pharmaceuticals Inc. | Shares withheld for tax | −6,277 | $12.82 | $80,471 |
| Jan 2, 2026 | Phathom Pharmaceuticals Inc. | Grant or award | +251,034 | — | — |
| Dec 17, 2025 | Phathom Pharmaceuticals Inc. | Grant or award | +62,038 | — | — |
| Dec 17, 2025 | Phathom Pharmaceuticals Inc. | Shares withheld for tax | −31,502 | $15.36 | $483,871 |
| Nov 28, 2025 | Phathom Pharmaceuticals Inc. | Option exercise | +90,000 | — | — |
| Nov 28, 2025 | Phathom Pharmaceuticals Inc. | Shares withheld for tax | −48,375 | $15.62 | $755,618 |
| Sep 25, 2025 | Phathom Pharmaceuticals Inc. | Option exercise | +90,000 | — | — |
| Sep 25, 2025 | Phathom Pharmaceuticals Inc. | Shares withheld for tax | −48,375 | $11.66 | $564,053 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.